http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113845546-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c06986ab29a6b88b253c5773da71ba4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-321
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6571
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-02
filingDate 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d09b18c18ba2686fd834ca58fd91843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8ee696d2e54452389e3963839bfd78a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0931f2f4ea1cfb800d52596ae92e75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aefc02fec5b1f09ea9d8421076ad97f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905671231c36f058bf3bd2b013e54b04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da996ee41685d141daec01d2a2fe7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b2f780fabf55de9026918c288305579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_009106d4d81de74c08f4b9ab05619212
publicationDate 2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113845546-A
titleOfInvention Crystallized acetonitrile solvate of dioxaphosphepin derivative and preparation method and application thereof
abstract The present invention provides a crystalline acetonitrile solvate of 6,6' - [ [3,3',5,5' -tetra-tert-butyl- [1,1' -biphenyl ] -2,2' -diyl ] bis (oxy) ] bisdibenzo [ d, f ] [1,3,2] -dioxaphosphepin having an X-ray powder diffraction pattern with a diffraction peak at 2 Θ, said 2 Θ being selected from at least five of the following: 7.36 +/-0.20 degrees, 7.69 +/-0.20 degrees, 10.08 +/-0.20 degrees, 10.56 +/-0.20 degrees, 11.36 +/-0.20 degrees, 12.40 +/-0.20 degrees, 15.98 +/-0.20 degrees, 18.56 +/-0.20 degrees, 18.84 +/-0.20 degrees and 20.41 +/-0.20 degrees. Compared with an amorphous compound, the compound has the advantages of periodically and repeatedly arranged internal molecules in a three-dimensional space, long-range order, regular crystal structure, easier dispersion, low viscosity and difficult agglomeration, and is very suitable for industrial production and application.
priorityDate 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415008941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416018607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414497221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409941813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450479996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413550053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419881454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID576146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420184161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449041636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407649066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420005121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421966466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410524311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408194220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21966964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12977495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409301873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11651651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419810651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424621649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415195398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408074173

Total number of triples: 82.